Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Active not recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Triple Negative Breast Neoplasms 1

Interventions

pembrolizumab 98Specimen Handling 79Magnetic Resonance Spectroscopy 70Carboplatin 59Cisplatin 57Biopsy 56Nivolumab 55Radiotherapy 48Cyclophosphamide 46Paclitaxel 44Radiation 37durvalumab 34Dexamethasone 33olaparib 31Gemcitabine 31Etoposide 29Doxorubicin 29atezolizumab 27Rituximab 26Docetaxel 26Taxes 25Ipilimumab 25Bevacizumab 25Vincristine 24Lenalidomide 23Cytarabine 23Prednisone 22Platinum 22Pemetrexed 22X-Rays 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Mastectomy, Segmental × 90 days × Clear all
NCT02927912 2026-06-03

Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction

Ohio State University Comprehensive Cancer Center

Phase 2 Active not recruiting
108 enrolled 8 charts
Breast

Breast Neoplasms

NCT02883062 2026-05-28

Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
67 enrolled 16 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡